Overview

Cross-over Comparison of Gabapentin and Memantine as Treatment for Acquired Nystagmus

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
Involuntary oscillations of the eyes (nystagmus) impairs vision so that affected patients, who have neurological disorders such as Multiple Sclerosis (MS) , cannot read or watch TV. Two medicines have been reported to suppress nystagmus and improve vision in such patients: gabapentin and memantine. The investigators set out to test which of these two drug was more effective by carrying out a double-blind cross-over study. In this way, we could determine which drug worked best in each patient.
Phase:
N/A
Details
Lead Sponsor:
Case Western Reserve University
Treatments:
Gabapentin
gamma-Aminobutyric Acid
Memantine